DNA damage response inhibitors in pancreatic cancer: progress and challenges
{{output}}
Pancreatic cancer is one of the most lethal malignancies, with very limited treatment options beyond standard chemotherapy. The discovery of homologous recombination repair (HRR) deficiencies-such as BRCA1/2 and PALB2 mutations-has revealed a targetable vulner... ...